Top Markets
Coin of the day
Advicenne S.A. Advicenne S.A.

Advicenne S.A.

ALDVI
Rang in Aktien #28005
Advicenne S.A. operates as a specialized pharmaceutical firm, focusing on the... Advicenne S.A. operates as a specialized pharmaceutical firm, focusing on the innovation and commercialization of therapeutic solutions for various kidney-related disorders. The company's primary offering, Sibnayal, targets both distal renal tubular acidosis and cystinuria. Established in 2007, Advicenne S.A. maintains its principal offices in Paris, France.
Aktienkurs
$2.00
Zuletzt synchronisiert: 2026-08-19
Marktkapitalisierung
$29.13M
Veränderung (1 Tag)
0.24%
Veränderung (1 Jahr)
38.57%
Land
FR
Handel Advicenne S.A. (ALDVI)

Kategorie

Kursverlauf für Advicenne S.A. (ALDVI)
Höchster Schlusskurs: $1.97 am 2026-08-01

Niedrigster Schlusskurs: $16.55 am 2017-12-01
Kursverlauf der Aktie von Advicenne S.A. von 2017 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -10.86%
2025 5.44%
2024 -15.47%
2023 -46.62%
2022 -52.35%
2021 -23.46%
2020 17.73%
2019 -11.90%
2018 -30.68%
2017 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$122.11 -14.02%
AU
$753.28 5.84%
CH